LabCompass

Anna Leone

Medicine · The Ohio State University

Established · publishing since 1988

Publications

13

Citations

971

Est. group size

Recurring co-author estimate

Active years

37

Publishing since 1988

Research summary
AI-generated

Anna Leone's publicly available bibliographic record is very limited, making it difficult to characterize a clear research program. The one identifiable recent publication concerns real-world use of risankizumab, a biologic drug, for treating Crohn's disease, an inflammatory bowel condition. The listed OpenAlex topic tags (covering areas like nitric oxide biology, circadian rhythms, sleep and respiration, HIV complications, and asthma) show no relevance scores, suggesting these associations are weak or uncertain.

Inflammatory bowel diseaseCrohn's disease treatmentBiologic therapies (risankizumab)GastroenterologyClinical/real-world drug outcomes

Publication output has been minimal and sporadic over the last decade, with activity only appearing in 2023 and 2024.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 0.6/year recently
1718192021222023: 1 publication232024: 2 publications2242526
Recent publications
Publishes in
  • Gastroenterology×2
  • The American Journal of Gastroenterology×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile